Drug Enforcement D-0296-2023

Lack of sterility assurance

Status

Completed

Classification

Class II

Report Date

February 22, 2023

Termination Date

Product Information

Product description
HYDROMORPHONE (a) 1MG/ML IN NS, 50ML, 75 ML, 100ML, 175ML(NDC 00703-0018-01 and NDC 00409-2634-50) ; (b) 5MG/ML IN NS 60ML, 100ML, 250ML; pain, Rx only, used with a Curlin pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC# 00409-2634-50
Product quantity
37 bags
Reason for recall
Lack of sterility assurance
Recall initiation reason
Initial firm notification
Telephone
Distribution pattern
Dispensed to Patients Nationwide.

Location & Firm

Recalling firm
Sentara Infusion Services
Address
535 Independence Pkwy Ste 300, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0296-2023
Event ID
91466
Recall initiation date
December 27, 2022
Center classification date
February 15, 2023
Code info
Beyond Use Date: December 24-31, 2022
More code info